DIVIS LABORATORIES Financial Statement Analysis
|
||
The Revenues of DIVIS LABORATORIES have increased by 19.31% YoY .
The Earnings Per Share (EPS) of DIVIS LABORATORIES has increased by 36.93 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
DIVIS LABORATORIES Last 5 Annual Financial Results
[BOM: 532488|NSE : DIVISLAB]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹9,360 Cr | ₹7,845 Cr | ₹7,767 Cr | ₹8,960 Cr | ₹6,969 Cr |
Expenses | ₹6,391 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹5,079 Cr | ₹4,108 Cr |
Operating Profit (Excl OI) | ₹2,969 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr |
Other Income | ₹352 Cr | ₹339 Cr | ₹345 Cr | ₹116 Cr | ₹63 Cr |
Interest | ₹3.00 Cr | ₹4.00 Cr | ₹2.00 Cr | ₹2.00 Cr | ₹2.10 Cr |
Depreciation | ₹402 Cr | ₹378 Cr | ₹343 Cr | ₹312 Cr | ₹256 Cr |
Profit Before Tax | ₹2,916 Cr | ₹2,163 Cr | ₹2,369 Cr | ₹3,684 Cr | ₹2,666 Cr |
Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
Consolidated Net Profit | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
Earnings Per Share (Rs) | ₹82.68 | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 |
PAT Margin (%) | 23.29 | 20.28 | 23.33 | 32.94 | 28.38 |
ROE(%) | 15.35 | 12.15 | 14.89 | 28.16 | 23.90 |
ROCE(%) | 20.45 | 16.46 | 19.36 | 35.06 | 32.07 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 176,643.8 Cr |
Revenue (TTM) | : | ₹ 9,360.0 Cr |
Net Profit(TTM) | : | ₹ 2,191.0 Cr |
EPS (TTM) | : | ₹ 82.5 |
P/E (TTM) | : | 80.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
DIVIS LABORATORIES | -2% | 1.3% | 45.8% |
SUN PHARMACEUTICAL INDUSTRIES | -1.2% | 1.3% | 5.7% |
CIPLA | -0.6% | -2% | -1.7% |
TORRENT PHARMACEUTICALS | 1.4% | 11.9% | 15.7% |
DR REDDYS LABORATORIES | -1.2% | -6.7% | -8.4% |
MANKIND PHARMA | -1.5% | 12.7% | 26.7% |
ZYDUS LIFESCIENCES | -2% | -0.3% | -17.2% |
LUPIN | -1.8% | -0.5% | 5.4% |
AUROBINDO PHARMA | -3.2% | 1.2% | -18.1% |
DIVIS LABORATORIES Revenues
[BOM: 532488|NSE : DIVISLAB]
Y-o-Y | 19.31 % |
5 Yr CAGR | 7.65 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹9,360 Cr | 19.31 | |
Mar2024 | ₹7,845 Cr | 1.00 | |
Mar2023 | ₹7,767 Cr | -13.31 | |
Mar2022 | ₹8,960 Cr | 28.56 | |
Mar2021 | ₹6,969 Cr | - |
DIVIS LABORATORIES Operating Profit
[BOM: 532488|NSE : DIVISLAB]
Y-o-Y | 34.59 % |
5 Yr CAGR | 0.93 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,969 Cr | 34.59 | |
Mar2024 | ₹2,206 Cr | -6.88 | |
Mar2023 | ₹2,369 Cr | -38.96 | |
Mar2022 | ₹3,881 Cr | 35.65 | |
Mar2021 | ₹2,861 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 12.80 % |
5 Yr CAGR | -6.24 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 31.72% | 12.80 | |
Mar2024 | 28.12% | -7.80 | |
Mar2023 | 30.5% | -29.59 | |
Mar2022 | 43.32% | 5.53 | |
Mar2021 | 41.05% | - |
DIVIS LABORATORIES Profit After Tax
[BOM: 532488|NSE : DIVISLAB]
Y-o-Y | 36.94 % |
5 Yr CAGR | 2.51 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹2,191 Cr | 36.94 | |
Mar2024 | ₹1,600 Cr | -12.28 | |
Mar2023 | ₹1,824 Cr | -38.39 | |
Mar2022 | ₹2,960 Cr | 49.19 | |
Mar2021 | ₹1,984 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 14.84 % |
5 Yr CAGR | -4.82 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 23.29 % | 14.84 | |
Mar2024 | 20.28 % | -13.07 | |
Mar2023 | 23.33 % | -29.17 | |
Mar2022 | 32.94 % | 16.07 | |
Mar2021 | 28.38 % | - |
DIVIS LABORATORIES Earnings Per Share (EPS)
[BOM: 532488|NSE : DIVISLAB]
Y-o-Y | 36.93 % |
5 Yr CAGR | 2.55 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹83 | 36.93 | |
Mar2024 | ₹60 | -12.28 | |
Mar2023 | ₹69 | -38.29 | |
Mar2022 | ₹112 | 49.20 | |
Mar2021 | ₹75 | - |
DIVIS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532488|NSE : DIVISLAB]
Y-o-Y | 24.24 % |
5 Yr CAGR | -10.64 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 20.45% | 24.24 | |
Mar2024 | 16.46% | -14.98 | |
Mar2023 | 19.36% | -44.78 | |
Mar2022 | 35.06% | 9.32 | |
Mar2021 | 32.07% | - |
DIVIS LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹6,653.3 |
Current MarketCap | : | ₹ 176,643.8 Cr |
Updated EOD on | : | Jul 23,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2% |
1.3% |
45.8% |
SENSEX | 0.1% |
1% |
2.6% |
DIVIS LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE LARGEMIDCAP | 4.5% | 7.2% | 8.3% |
BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
BSE MOMENTUM INDEX | 0.7% | 1.8% | -2.2% |
BSE SENSEX SIXTY | -0% | 1% | NA |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY100 ALPHA 30 | 1.1% | 1.5% | -7.9% |
NIFTY200 ALPHA 30 | 0.6% | 1.1% | -6.1% |
NIFTY200 MOMENTUM 30 | 0.2% | -1.1% | -10.2% |
NIFTY100 ESG | 0.2% | 1.8% | 2.2% |
NIFTY500 MOMENTUM 50 | -0% | -1.4% | -11.5% |
You may also like the below Video Courses
FAQ about DIVIS LABORATORIES Financials
How the annual revenues of DIVIS LABORATORIES have changed ?
The Revenues of DIVIS LABORATORIES have increased by 19.31% YoY .
How the Earnings per Share (EPS) of DIVIS LABORATORIES have changed?
The Earnings Per Share (EPS) of DIVIS LABORATORIES has increased by 36.93 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs